The largest database of trusted experimental protocols

Cg prkdcscid il2rgtm1wjl szj

Manufactured by Jackson ImmunoResearch
Sourced in Montenegro, United States

The Cg-Prkdcscid Il2rgtm1Wjl/SzJ is a genetically engineered mouse strain. It is a severe combined immunodeficiency (SCID) model with a targeted mutation in the Il2rg gene, which is involved in immune system development.

Automatically generated - may contain errors

6 protocols using cg prkdcscid il2rgtm1wjl szj

1

Establishing PDX Mouse Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
4–5-week old NOD. Cg-Prkdcscid Il2rgtm1Wjl/SzJ (aka, NSG) female mice were obtained from Jackson Laboratories (Sacramento, CA) and implanted subcutaneously in the flank with ~1 mm3 cancerous tissue from previously established PDX tissue. Xenografts were propagated and harvested when they reached the allowable size of ~1.5 cm in any direction. After mice were euthanized the tumors were resected and flash frozen in liquid nitrogen until RNA preparation. The study was conducted under an approved IACUC protocol.
+ Open protocol
+ Expand
2

Conditional Foxp3 Knockout in Breast

Check if the same lab product or an alternative is used in the 5 most similar protocols
Transgenic Tg (MMTV-Cre) 4Mam/J mice with Cre under control of the mouse mammary tumor promoter (MMTV) and immunodeficient NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Male MMTV-Cre mice were crossed to female Foxp3flox/flox mice (20 (link), 23 (link)) to generate breast Foxp3 conditional knockout (cKO, MMTV-Cre × Foxp3flox/flox) mice. All animal experiments were conducted in accordance with accepted standards of animal care and approved by the Institutional Animal Care and Use Committee of University of Alabama at Birmingham (UAB).
+ Open protocol
+ Expand
3

Investigating SIRT2 Knockout Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
C57BL/6J mice, Pmel mice with gp100-reactive TCR:
B6.Cg-Thy1a/Cy Tg(TcraTcrb)8Rest/J, OT-II
mice with MHC II-restricted OVA-specific TCR: B6.Cg-Tg(TcraTcrb)425Cbn/J,
Sirt2−/− mice:
B6.129-Sirt2tm1.1Fwa/J and NSG mice:
NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ were purchased from The Jackson
Laboratory. Pmel mice and OT-II mice were crossed with
Sirt2−/− mice to generate
Sirt2−/− Pmel mice and
Sirt2−/− OT-II mice,
respectively. All mice were bred and maintained under specific pathogen-free
conditions at the animal facility of H. Lee Moffitt Cancer Center. All
animal protocols were approved by the Institutional Animal Care and Use
Committee (IACUC). Mice were used at 7–8 weeks of age with age- and
sex-matched controls.
+ Open protocol
+ Expand
4

In Vivo Anti-Tumor Evaluation of P2Et in NSG Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
NOD. Cg-Prkdcscid IL2rgtm1Wjl/SzJ, most often known by their branded name, NOD scid gamma (abbreviated as NSG) mice (3–4 weeks old) were purchased from The Jackson Laboratory (Bar Harbor, ME). All mice were housed in a pathogen free facility in microisolator cages following the established protocols of the Ethics Committee of the Science Faculty and National and International Legislation for Live Animal Experimentation (Colombia Republic, Resolution 08430, 1993; National Academy of Sciences, 2010) (Act 006-2014, approved on June 20, 2014). Mice were housed in polyethylene cages with sterile food and water ad libitum, controlled temperature, and a 12 h light/dark cycle. Before treatment, the mice were familiarized for 1 week under standard conditions. The ethics committee of the science faculty approved the format for animals use on June 24, 2014.
1 × 106 MDA-MB-468 cells were orthotopically transplanted on NSG mice. After 8 days, the mice (4 mice per group) were treated intraperitoneally with P2Et (18.7 mg/kg) or PBS twice per week, until endpoint. Tumours were measured with Vernier callipers twice a week, and the experiment was finished when mice showed end-point symptoms, humanely defined in the protocol. The tumour volume was calculated using the following formula: tumour volume (mm3) = [(Width)2 × Length]/2.
+ Open protocol
+ Expand
5

Subcutaneous Tumor Xenograft in NSG Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male and female (8–12 weeks of age) NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) breeder pairs were purchased from The Jackson Laboratory (Bar Harbor, ME, USA) and bred under specific pathogen-free conditions in sterile ventilated racks in the animal care facility at the University of Wisconsin-Madison. The study was approved by the Animal Care and Use Committee of the University of Wisconsin-Madison. Tumor cells (7-8 x 106) were injected subcutaneously into the right flank of each mouse.
+ Open protocol
+ Expand
6

Establishment of Pancreatic Tumor PDX Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
All pancreatic tumour tissue specimens were obtained during clinically indicated collection procedures with informed consent and authorised through institutional review board (IRB)-approved bio-specimen protocol number 14-091 at Memorial Sloan Kettering Cancer Center. Samples were de-identified before receipt for use in these approved studies. Samples were either used within 30 min to 1 h of collection for ex vivo studies or were minced, mixed with matrigel (50:50) and implanted subcutaneously in the flank of female NSG mice (Jackson Laboratory, Bar Harbour, NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ, female, 20–25 g, 8 weeks old, IMSR Cat# JAX:005557, RRID: IMSR_JAX:005557) to generate PDX models, as previously described51 (link). All mice were cared for in accordance with guidelines approved by the Memorial Sloan Kettering Cancer Center Institutional Animal Care and Use Committee under an approved IACUC protocol (04-03-009).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!